Ionis Pharmaceuticals (NASDAQ:IONS) has been analyzed by 12 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 8 | 2 | 2 | 0 | 0 |
| Last 30D | 1 | 0 | 1 | 0 | 0 |
| 1M Ago | 5 | 1 | 0 | 0 | 0 |
| 2M Ago | 1 | 0 | 1 | 0 | 0 |
| 3M Ago | 1 | 1 | 0 | 0 | 0 |
Analysts have recently evaluated Ionis Pharmaceuticals and provided 12-month price targets. The average target is $63.83, accompanied by a high estimate of $82.00 and a low estimate of $53.00. Marking an increase of 8.04%, the current average surpasses the previous average price target of $59.08.
Analyzing Analyst Ratings: A Detailed Breakdown
The standing of Ionis...
ログインすると全部閲覧できます。
ログイン
